Loading...

Doctor: $500M Ranbaxy fine simply "cost of doing business"

| Web Extra: Former Ranbaxy employee Dr. Kathy Spreen says the $500 million fine the generic drug maker paid for drug safety violations "just wasn't significant enough for them to even notice." Spreen tells John Miller consumers should know they can refuse drugs from untrustworthy companies.